Sonoma Pharmaceuticals Inc. Common Stock (SNOA)
Stock · NASDAQ · Health Care
$1.15as of 10/16/2026
Price chart
Active signals
SNOA Signal Track Record
How signals performed across all stocks →What SNOA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | -7.4% | 30% | October 8, 2026 |
| Bollinger Band Breakdown | 19 | -9.2% | 42% | October 8, 2026 |
| Bollinger Band Breakout | 19 | -17.7% | 11% | August 7, 2026 |
| 200-Day Moving Average TouchActive now | 4 | -0.7% | 50% | December 29, 2025 |
| Any 20-session window (baseline) | -5.9% | 35% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SNOA
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peel…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 10
- Website
- sonomapharma.com/
Fundamentals
- 1-day range
- $1.12$1.23
- Market cap
- $5.99M
- P/E (trailing)
- —
- P/E (forward)
- -2.00
- EPS (trailing)
- $-1.22
- Dividend yield
- —
- Beta
- 1.32
- Avg. volume
- 106.6K
- Dividend pay date
- June 20, 2019
How Sonoma Pharmaceuticals Inc. Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Jun 16, 2026 · via SEC EDGAR / Finnhub
Sonoma Pharmaceuticals Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SNOASonoma Pharmaceuticals Inc. Common Stock$1.12▼ 2.61%Market cap $5.99MP/E —$0.8501$4.25
- NVNOenVVeno Medical Corporation Common Stock$7.47▼ 5.74%Market cap $6.93MP/E —$7.01$30.8
- XAIRBeyond Air Inc. Common Stock$2.16▼ 2.26%Market cap $4.93MP/E —$2.31$55.6
- INBSIntelligent Bio Solutions Inc. Common Stock$1.5▲ 4.17%Market cap $4.76MP/E —$1.35$24.9
- PMIPicard Medical Inc. Common Stock$12.75▲ 27.50%Market cap $7.27MP/E —$2.65$684
- VVOSVivos Therapeutics Inc. Common Stock$0.131▼ 8.39%Market cap $4.47MP/E —$0.1276$3.28
- GCTKGlucoTrack Inc. Common Stock$0.725▼ 12.86%Market cap $4.25MP/E 0.07$1.77$136.29
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SNOA Sonoma Pharmaceuticals Inc. Common Stock | $5.99M | — | $1.12 | ▼ 2.61% | $0.8501$4.25 |
| NVNO enVVeno Medical Corporation Common Stock | $6.93M | — | $7.47 | ▼ 5.74% | $7.01$30.8 |
| XAIR Beyond Air Inc. Common Stock | $4.93M | — | $2.16 | ▼ 2.26% | $2.31$55.6 |
| INBS Intelligent Bio Solutions Inc. Common Stock | $4.76M | — | $1.5 | ▲ 4.17% | $1.35$24.9 |
| PMI Picard Medical Inc. Common Stock | $7.27M | — | $12.75 | ▲ 27.50% | $2.65$684 |
| VVOS Vivos Therapeutics Inc. Common Stock | $4.47M | — | $0.131 | ▼ 8.39% | $0.1276$3.28 |
| GCTK GlucoTrack Inc. Common Stock | $4.25M | 0.07 | $0.725 | ▼ 12.86% | $1.77$136.29 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Weigerstorfer Philippe · July 9, 2026 · Grant10.0K
- Trombly Amy Moss · July 9, 2026 · Grant10.0K
- Jacoby Vanessa · July 9, 2026 · Grant10.0K
- DVONCH JEROME J · July 9, 2026 · Grant10.0K
- Dal Poggetto John · July 9, 2026 · Grant7.5K
- MCLAUGHLIN JOHN · July 9, 2026 · Grant10.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 67.2K
- Total value held
- $143.2K
- Institutional holders
- 15
- Unknown19.9K
- Unknown18.8K
- Unknown12.0K
- Unknown11.2K
- Unknown2.0K
- Unknown1.4K
- Unknown1.2K
- Unknown500
- Unknown113
- Unknown25
See the full, filterable feed with live charts on the MarketWall dashboard.